Company intelligence / Profile preview

FinLead

Ownership
Private
Development stage
Other
01

Overview

FinLead is an active mergers & acquisitions advisory firm specializing in technology companies. Founded around 2014 and based primarily in India—with some presence noted in the US and UK—it provides strategic advice for tech entrepreneurs on selling or scaling their businesses. There are no indications that FinLead operates within the life sciences, biotechnology, pharmaceutical or healthcare sectors. No clinical pipeline exists nor does it develop therapeutic modalities or target medical indications. The similarly named “Finlead Team” focuses on fintech solutions but also has no connection to health-related industries.

Industry
Consulting

Beyond the preview

Go deeper on FinLead.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FinLead.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call